Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dan L Longo, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. Z01AG000109 (LONGO, DAN L)
    NIH
    Cell Biology Of Lymphoma
    Role: Principal Investigator
  2. Z01AG000110 (LONGO, DAN L.)
    NIH
    Role Of Cadherins In Tumor Progression
    Role: Principal Investigator
  3. Z01AG000114 (LONGO, DAN L.)
    NIH
    Tumor-induced Immunosuppression
    Role: Principal Investigator
  4. Z01AG000115 (LONGO, DAN L.)
    NIH
    Rapamycin-sensitive pathway of T cell Activation
    Role: Principal Investigator
  5. Z01AG000116 (LONGO, DAN L.)
    NIH
    Regulation Of Mutant P53
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Khuat LT, Vick LV, Dunai C, Collins CP, More SK, Le CT, Pai CS, Stoffel KM, Maverakis E, Canter RJ, Monjazeb AM, Longo DL, Abedi M, Choi E, Blazar BR, Dave M, Murphy WJ. Increased efficacy of dual pro-inflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 2021 Aug 23. PMID: 34424962.
    Citations:    Fields: